248
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Predictors of Mortality Among Adult HIV-Infected Patients Taking Antiretroviral Therapy (ART) in Harari Hospitals, Ethiopia

ORCID Icon, & ORCID Icon
Pages 727-736 | Published online: 02 Jul 2021

References

  • Gunda DW, Nkandala I, Kilonzo SB, Kilangi BB, Mpondo BC. Prevalence and risk factors of mortality among adult HIV patients initiating ART in rural setting of HIV care and treatment services in North Western Tanzania: a retrospective cohort study. J Sexual Transmit Dis. 2017;2017:2017. doi:10.1155/2017/7075601
  • WHO. Global Health Sector Response to HIV, 2000–2015: Focus on Innovations in Africa: Progress Report. WHO; 2015.
  • World Health Organization. Global Health Sector Strategy on HIV 2016–2021. Towards Ending AIDS. World Health Organization; 2016.
  • HIV/AIDS JUNPo, HIV/AIDS JUNPo. Global AIDS Update 2016. Geneva: UNAIDS; 2016.
  • Ethiopia FMoH. National guidelines for comprehensive HIV prevention, care and treatment View. 2014.
  • WHO. Guidelines for Antiretroviral Drug Therapy in Kenya. WHO; 2005.
  • Biset Ayalew M. Mortality and its predictors among HIV infected patients taking antiretroviral treatment in Ethiopia: a systematic review. AIDS Res Treat. 2017;2017:5415298. doi:10.1155/2017/5415298
  • Misgina KH, Weldu MG, Gebremariam TH, et al. Predictors of mortality among adult people living with HIV/AIDS on antiretroviral therapy at Suhul Hospital, Tigrai, Northern Ethiopia: a retrospective follow-up study. J Health Popul Nutr. 2019;38(1):37. doi:10.1186/s41043-019-0194-0
  • Kebede A, Tessema F, Bekele G, Kura Z, Merga H. Epidemiology of survival pattern and its predictors among HIV positive patients on highly active antiretroviral therapy in Southern Ethiopia public health facilities: a retrospective cohort study. AIDS Res Ther. 2020;17(1):49. doi:10.1186/s12981-020-00307-x
  • Lakoh S, Jiba DF, Kanu JE, et al. Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study. BMC Public Health. 2019;19(1):1320.
  • Ssempijja V, Namulema E, Ankunda R, et al. Temporal trends of early mortality and its risk factors in HIV-infected adults initiating antiretroviral therapy in Uganda. EClinicalMedicine. 2020;28:100600. doi:10.1016/j.eclinm.2020.100600
  • Centers for Disease Control and Prevention. CDC Fact Sheet: Today’s HIV/AIDS Epidemic. Centers for Disease Control and Prevention; 2016.
  • Digaffe T, Seyoum B, Oljirra L. Survival and predictors of mortality among adults on antiretroviral therapy in selected public Hospitals in Harar, Eastern Ethiopia. J Trop Dis. 2014;2(05):2. doi:10.4172/2329-891X.1000148
  • Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 2008;8(1):52. doi:10.1186/1471-2334-8-52
  • Tadele A, Shumey A, Hiruy N. Survival and predictors of mortality among adult patients on highly active antiretroviral therapy at debre-markos referral hospital, North West Ethiopia; a retrospective cohort study. J AIDS Clin Res. 2014;5(280):2.
  • Ababa A. Report on the 2014 Round Antenatal Care Based Sentinel HIV Surveillance in Ethiopia. Ethiop Public Heal Instititute; 2015.
  • Damtew B, Mengistie B, Alemayehu T. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan African Med J. 2015;22(1). doi:10.11604/pamj.2015.22.138.4352
  • Tiruneh G, Getahun A, Adeba E. Assessing the impact of isoniazid preventive therapy (IPT) on tuberculosis incidence and predictors of tuberculosis among adult patients enrolled on ART in Nekemte Town, Western Ethiopia: a retrospective cohort study. Interdiscip Perspect Infect Dis. 2019;2019:1–8. doi:10.1155/2019/1413427
  • Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(2):e016961. doi:10.1136/bmjopen-2017-016961
  • Setegn T, Takele A, Gizaw T, Nigatu D, Haile D. Predictors of mortality among adult antiretroviral therapy users in southeastern Ethiopia: retrospective cohort study. AIDS Res Treat. 2015;2015:1–8. doi:10.1155/2015/148769
  • Rao P, Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. J Am Stat Assoc. 2000;95(450):681. doi:10.2307/2669422
  • Pandey A, Galvani AP. The global burden of HIV and prospects for control. Lancet HIV. 2019;6(12):e809–e11. doi:10.1016/S2352-3018(19)30230-9
  • Belay H, Alemseged F, Angesom T, Hintsa S, Abay M. Effect of late HIV diagnosis on HIV-related mortality among adults in general hospitals of Central Zone Tigray, northern Ethiopia: a retrospective cohort study. Hiv/Aids (Auckland, NZ). 2017;9:187.
  • Tadesse K, Haile F, Hiruy N, Sued O. Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study. PLoS One. 2014;9(1):e87392. doi:10.1371/journal.pone.0087392
  • Biadgilign S, Reda AA, Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther. 2012;9(1):15. doi:10.1186/1742-6405-9-15
  • Tsegaye AT, Alemu W, Ayele TA. Incidence and determinants of mortality among adult HIV infected patients on second-line antiretroviral treatment in Amhara region, Ethiopia: a retrospective follow up study. Pan Afr Med J. 2019;33. doi:10.11604/pamj.2019.33.89.16626
  • Joseph N, Sinha U, Tiwari N, Ghosh P, Sindhu P. Prognostic factors of mortality among adult patients on antiretroviral therapy in India: a hospital based retrospective cohort study. Biomed Res Int. 2019;2019:1–10. doi:10.1155/2019/1419604
  • Kempton J, Hill A, Levi JA, Heath K, Pozniak A. Most new HIV infections, vertical transmissions and AIDS-related deaths occur in lower-prevalence countries. J Virus Erad. 2019;5(2):92–101. doi:10.1016/S2055-6640(20)30058-3
  • Ayele H, Van Mourik M, Bonten M. Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia. Int J Tuberc Lung Dis. 2016;20(10):1342–1347. doi:10.5588/ijtld.15.0805
  • Mindachew M, Deribew A, Tessema F, Biadgilign S. Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia. BMC Public Health. 2011;11(1):916. doi:10.1186/1471-2458-11-916
  • Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):460. doi:10.1186/s12879-020-05177-2
  • Edessa D, Likisa J, Bellamy SL. A description of mortality associated with IPT plus ART compared to ART alone among HIV-infected individuals in Addis Ababa, Ethiopia: a cohort study. PLoS One. 2015;10(9):e0137492–e. doi:10.1371/journal.pone.0137492
  • Ayele HT, van Mourik MS, Bonten MJ. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study. BMC Infect Dis. 2015;15(1):1–8. doi:10.1186/s12879-015-1089-3
  • Nyathi S, Dlodlo RA, Satyanarayana S, et al. Isoniazid preventive therapy: uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe. PLoS One. 2019;14(10):e0223076. doi:10.1371/journal.pone.0223076
  • Abuto W, Abera A, Gobena T, Dingeta T, Markos M. Survival and predictors of mortality among HIV positive adult patients on highly active antiretroviral therapy in public hospitals of Kambata Tambaro Zone, Southern Ethiopia: a retrospective cohort study. HIV AIDS (Auckl). 2021;13:271–281. doi:10.2147/HIV.S299219
  • Tachbele E, Ameni G. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study. Epidemiol Health. 2016;38. doi:10.4178/epih.e2016049
  • Muhula SO, Peter M, Sibhatu B, Meshack N, Lennie K. Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya. Pan African Med J. 2015;20(1). doi:10.11604/pamj.2015.20.63.4865
  • Bajpai R, Chaturvedi H, Jayaseelan L, et al. Effects of antiretroviral therapy on the survival of human immunodeficiency virus-positive adult patients in Andhra Pradesh, India: a retrospective cohort study, 2007–2013. J Prev Med Public Health. 2016;49(6):394. doi:10.3961/jpmph.16.073
  • Wisaksana R, Sumantri R, Indrati AR, et al. Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infect Dis. 2011;11(1):213. doi:10.1186/1471-2334-11-213
  • Santiago-Rodríguez EJ, Mayor AM, Fernández-Santos DM, Ruiz-Candelaria Y, Hunter-Mellado RF. Anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Res Notes. 2014;7(1):439. doi:10.1186/1756-0500-7-439
  • Muyaya LM, Young T, Loveday M. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: a retrospective cohort study. Medicine. 2018;97(16):e0486. doi:10.1097/MD.0000000000010486
  • Enderis BO, Hebo SH, Debir MK, Sidamo NB, Shimber MS. Predictors of time to first line antiretroviral treatment failure among adult patients living with HIV in public health facilities of Arba Minch Town, Southern Ethiopia. Ethiop J Health Sci. 2019;29(2):175–186. doi:10.4314/ejhs.v29i2.4
  • Seyoum D, Degryse J-M, Kifle YG, et al. Risk factors for mortality among adult HIV/AIDS patients following antiretroviral therapy in Southwestern Ethiopia: an assessment through survival models. Int J Environ Res Public Health. 2017;14(3):296. doi:10.3390/ijerph14030296
  • Rai S, Mahapatra B, Sircar S, et al. Adherence to antiretroviral therapy and its effect on survival of HIV-infected individuals in Jharkhand, India. PLoS One. 2013;8(6):e66860. doi:10.1371/journal.pone.0066860
  • Kang R, Luo L, Chen H, et al. Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study. BMJ Open. 2019;9(3):e025666. doi:10.1136/bmjopen-2018-025666
  • Liu P, Liao L, Xu W, et al. Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015. Medicine. 2018;97(50):e13555. doi:10.1097/MD.0000000000013555
  • Cavalcanti A, de Alencar Ximenes RA, Montarroyos UR, d’Albuquerque PM, Fonseca RA, de Barros Miranda-filho D. Effectiveness of four antiretroviral regimens for treating people living with HIV. PLoS One. 2020;15(9):e0239527. doi:10.1371/journal.pone.0239527
  • Kiros M, Alemayehu DH, Geberekidan E, et al. Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia. Retrovirology. 2020;17(1):1–10. doi:10.1186/s12977-020-00542-0